Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Publication
, Journal Article
Published in: Open Forum Infectious Diseases
April 4, 2023
Duke Scholars
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
April 4, 2023
Volume
10
Issue
4
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals. (2023). Open Forum Infectious Diseases, 10(4). https://doi.org/10.1093/ofid/ofad198
“Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.” Open Forum Infectious Diseases 10, no. 4 (April 4, 2023). https://doi.org/10.1093/ofid/ofad198.
“Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.” Open Forum Infectious Diseases, vol. 10, no. 4, Oxford University Press (OUP), Apr. 2023. Crossref, doi:10.1093/ofid/ofad198.
Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals. Open Forum Infectious Diseases. Oxford University Press (OUP); 2023 Apr 4;10(4).
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
April 4, 2023
Volume
10
Issue
4
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences